Status:
COMPLETED
Use of PRP in Endometrial Reconstruction
Lead Sponsor:
Fundación IVI
Conditions:
Asherman Syndrome
Endometrial Atrophy
Eligibility:
FEMALE
25-40 years
Brief Summary
Infertility, which affected 48.5 million couples worldwide in 2010 alone, has many causes; some causes result from issues related to the endometrium. Unfortunately, no cure exists for medical conditio...
Detailed Description
The objective is to know the effect of these regenerative factors obtained from Platelet-Rich Plasma in an immunodeficient murine model with AS/EA Blood from patients with Asherman's Syndrome (AS) and...
Eligibility Criteria
Inclusion
- Participants diagnosed with Asherman Syndrome and Endometrial Atrophy by Hysteroscopy.
- No pregnancy after hormonal treatment.
Exclusion
- Psychiatric diseases.
Key Trial Info
Start Date :
July 18 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT03249415
Start Date
July 18 2017
End Date
December 31 2023
Last Update
March 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IVI Barcelona
Barcelona, Spain